Lipid metabolism disorders in patients with hypertension and diabetes mellitus: development and current treatment options-Reference-Cited by-同舟云学术

Lipid metabolism disorders in patients with hypertension and diabetes mellitus: development and current treatment options

Published:2023-06-30 Issue:8 Volume:22 Page:3656
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Podzolkov V. I.¹^ORCID,Tarzimanova A. I.¹^ORCID,Abramova A. A.¹^ORCID,Vetluzhskaya M. V.¹^ORCID,Medvedev I. D.¹^ORCID,Loria I. Zh.¹^ORCID

Affiliation:

1. I. M. Sechenov First Moscow State Medical University

Abstract

The article presents the main mechanisms of development of lipid metabolism disorders and endothelial dysfunction in patients with hypertension (HTN) and type 2 diabetes (T2D), and their contribution to cardiovascular events. Modern approaches to the treatment of hypertension and dyslipidemia in people with type 2 diabetes are considered from the standpoint of the latest clinical guidelines, focusing on fixed-dose combinations as a means of an integrated approach to managing risk factors in comorbid patients. Data are presented on the efficacy and safety of fixed-dose combination of lisinopril, amlodipine and rosuvastatin in patients with hypertension and T2D.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine,Education

Reference43 articles.

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-80. doi:10.1016/S0140-6736(21)01330-1.

2. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study). Rational Pharmacotherapy in Cardiology. 2019;15(4):450-66. (In Russ.) doi:10.20996/1819-6446-2019-15-4-450-466.

3. Dedov II, Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-21. (In Russ.) doi:10.14341/DM12759.

4. Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2. Systemic Hypertension. 2020;17(1):7-45. (In Russ.) doi:10.26442/2075082X.2020.1.200051.

5. Zhernakova YuV, Chazova IE, Oshchepkova EV, et al. The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results. Systemic Hypertension. 2018;15(1):56-62. (In Russ.) doi:10.26442/2075-082X_15.1.56-62.